• 25-Hydroxycholesterol Reprograms Tumor Macrophages

  2026-09-01

  Xiao et al. identify CH25H and lysosomal 25-hydroxycholesterol as an immunometabolic checkpoint that connects sterol handling to AMPKα–STAT6 signaling in tumor-associated macrophages. The study shows that targeting this axis can improve T-cell surveillance and enhance anti-PD-1 efficacy, providing a mechanistic framework for studying macrophage-mediated tumor immune suppression.

• CGP 55845 hydrochloride in Synaptic Assays

  2026-09-01

  CGP 55845 hydrochloride gives researchers a selective way to separate GABAB receptor signaling from astrocytic GAT-3 mechanisms in dentate gyrus experiments. This practical guide combines concentration planning, electrophysiology workflows, neurotransmitter release modulation, and troubleshooting for reproducible in vitro studies.

• Early Life Adversity, Oxytocin, and Innate Fear

  2026-08-31

  Tan and colleagues show that social deprivation during a defined early-life window weakens looming-evoked innate defensive behavior in mice through reduced oxytocin signaling in the intermediate and deep superior colliculus. By combining behavioral testing, receptor knockdown, circuit analysis, and intranasal oxytocin rescue, the study connects early adversity with a specific threat-processing pathway while highlighting important limits for clinical translation.

• Ertapenem and the Mobility of Carbapenem Resistance

  2026-08-31

  Ertapenem is more than a broad-spectrum susceptibility reagent: it can help translational researchers connect PBP inhibition, carbapenemase activity, plasmid mobility, and strain relatedness. This thought-leadership guide uses recent CREC surveillance findings from Guangdong to outline a mobility-aware framework for antibiotic resistance research.

• Protease Inhibitor Cocktail for NPC Workflows

  2026-08-30

  Protect protein endpoints in DHODH and TP53 experiments with a broad-spectrum lysis strategy that covers multiple protease classes. The separate EDTA component enables metalloprotease control when compatible, while selective omission or removal supports IMAC, kinase, and other metal-sensitive workflows.

• Allosteric Biosensor Tracks Endogenous Protein Dynamics

  2026-08-29

  The reference study introduces circStep, an allosteric, genetically encoded RNA-aptamer biosensor that converts endogenous protein binding into fluorescence without tagging the protein itself. Its design supports live-cell visualization of native protein localization, abundance changes, and nucleocytoplasmic transport, while also providing a potential imaging-based route for screening relocalization-modulating compounds.

• Selonsertib (GS-4997): From ASK1 to Renal Injury

  2026-08-28

  Selonsertib (GS-4997) is an ATP-competitive ASK1 inhibitor for dissecting oxidative stress, inflammation, and fibrosis signaling. This article develops a renal assay framework that separates target engagement from tissue-level phenotype and clarifies what lupus nephritis findings can—and cannot—tell diabetic kidney disease research.

• Oleanolic Acid in Dual-Loaded Liposome Research

  2026-08-28

  Oleanolic acid combines a lipophilic triterpenoid scaffold with a practical challenge: accurate quantification after co-encapsulation with a hydrophilic compound. This workflow shows how to use solvent control, nanoparticle exclusion HPLC, and mass-balance checks to improve dual-loaded liposome studies while keeping antiviral and immune-pathway claims appropriately evidence-based.

• JDJM Modulates Wnt/β-Catenin in Knee Osteoarthritis

  2026-08-27

  The reference study combines rabbit synovial fibroblast experiments with a rabbit knee osteoarthritis model to investigate how Jiawei Duhuo Jisheng mixture affects inflamed synovium. Its central finding is that JDJM suppresses Wnt/β-catenin-associated transcription, inflammatory signaling, and matrix-degrading activity, supporting synovium-focused mechanisms in osteoarthritis research.

• ECL Western Blotting Substrate: Practical Guide

  2026-08-27

  ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection by chemiluminescence. It is intended for HRP-based Western blot workflows using X-ray film or CCD imaging, not for fluorescent or radioisotopic detection.

• AG-490 Workflow for JAK2/STAT6 Studies

  2026-08-26

  AG-490 (Tyrphostin B42) provides a practical pharmacological probe for separating JAK2-associated signaling from EGFR, ErbB2, STAT, and MAPK effects. This workflow translates exosome-driven macrophage polarization findings in hepatocellular carcinoma into controlled cell-based assays with dosing, controls, and troubleshooting guidance.

• Astrocytic GAT-3 Shapes Dentate Gyrus Memory

  2026-08-26

  The reference study identifies astrocytic GAT-3 as an active regulator of dentate gyrus synaptic transmission, linking GABA uptake to astrocytic Ca2+ signaling, presynaptic GluN2B-containing NMDARs, and contextual fear memory. Its combined electrophysiological, optogenetic, imaging, histological, and behavioral strategy provides a mechanistic framework for studying glia-dependent neurotransmission and hippocampal plasticity.

• Canagliflozin: SGLT2 Inhibitor Kidney Workflows

  2026-08-25

  Canagliflozin enables researchers to connect renal glucose reabsorption inhibition with mitochondrial structure, respiration, and kidney injury endpoints. This practical workflow guide shows how to formulate A8333, design proximal tubular assays, interpret sex-dependent responses, and troubleshoot metabolic readouts.

• Homoharringtonine: Cancer and Antiviral Workflows

  2026-08-25

  Homoharringtonine is a ribosome-targeted cytotoxic alkaloid for connecting leukemia research, cancer biology, and SARS-CoV-2 antiviral research in controlled cell-based assays. This guide translates its protein-elongation mechanism into practical setup, protocol, optimization, and troubleshooting decisions while separating published findings from recommended starting conditions.

• RNASEH1-AS1 as a HCC Biomarker and Target

  2026-08-24

  The reference study integrates TCGA-based transcriptomics, prognostic modeling, immune-infiltration analysis, and laboratory validation to characterize RNASEH1-AS1 in hepatocellular carcinoma. Its findings support RNASEH1-AS1 as a candidate diagnostic, prognostic, and oncogenic biomarker while identifying DKC1-associated RNA stability as a mechanistic lead for further investigation.

8109 records 1/541 page Next 12345 下5页 Last page